Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh T Packiam

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
Therapeutic Advances in Urology|February 3, 2016
The role of mycobacterial cell wall nucleic acid complex in the treatment of bacillus Calmette-Guérin failures for non-muscle-invasive bladder cancerVignesh T Packiam, Shane M Pearce, Gary D Steinberg
Journal of Endourology|May 19, 2018
Robot-Assisted Laparoscopic AdrenalectomyVignesh T Packiam, Nimrod S Barashi, Arieh L Shalhav
Cancer|January 24, 2017
Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-GuérinVignesh T Packiam, Scott C Johnson, Gary D Steinberg
European Urology|November 20, 2022
Re: Khyati Meghani, Lauren Folgosa Cooley, Bonnie Choy, et al. First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin. Eur Urol. 2022;82:602-10Ryan L Steinberg, Michael A O'Donnell, Vignesh T Packiam
Current Urology Reports|November 30, 2019
Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG ShortageVignesh T Packiam, Ryan P Werntz, Gary D Steinberg
Urology|July 12, 2016
Author ReplyAndrew J Cohen, Vignesh T Packiam, Gregory T Bales
Urology|May 21, 2023
EDITORIAL COMMENTMadison M Wahlen, Ian M McElree, Vignesh T Packiam
The Journal of Urology|March 31, 2023
Nonrisk-adapted Sequential Intravesical Gemcitabine and Docetaxel for Nonmuscle-invasive Bladder Cancer: The Time Is NowRyan L Steinberg, Michael A O'Donnell, Vignesh T Packiam
Expert Opinion on Pharmacotherapy|October 16, 2023
Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancerMohamad Abou Chakra, Vignesh T Packiam, Michael A O'Donnell
Annals of Surgical Oncology|February 10, 2026
ASO Practice Guidelines Series: Surgical Management of Bladder Cancer RelapseCan Aydogdu, Sean T McSweeney, Vignesh T Packiam, et al.
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Therapeutic Advances in Urology|February 3, 2016
The role of mycobacterial cell wall nucleic acid complex in the treatment of bacillus Calmette-Guérin failures for non-muscle-invasive bladder cancerVignesh T Packiam, Shane M Pearce, Gary D Steinberg
Journal of Endourology|May 19, 2018
Robot-Assisted Laparoscopic AdrenalectomyVignesh T Packiam, Nimrod S Barashi, Arieh L Shalhav
Cancer|January 24, 2017
Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-GuérinVignesh T Packiam, Scott C Johnson, Gary D Steinberg
European Urology|November 20, 2022
Re: Khyati Meghani, Lauren Folgosa Cooley, Bonnie Choy, et al. First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin. Eur Urol. 2022;82:602-10Ryan L Steinberg, Michael A O'Donnell, Vignesh T Packiam
Current Urology Reports|November 30, 2019
Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG ShortageVignesh T Packiam, Ryan P Werntz, Gary D Steinberg
Urology|July 12, 2016
Author ReplyAndrew J Cohen, Vignesh T Packiam, Gregory T Bales
Urology|May 21, 2023
EDITORIAL COMMENTMadison M Wahlen, Ian M McElree, Vignesh T Packiam
The Journal of Urology|March 31, 2023
Nonrisk-adapted Sequential Intravesical Gemcitabine and Docetaxel for Nonmuscle-invasive Bladder Cancer: The Time Is NowRyan L Steinberg, Michael A O'Donnell, Vignesh T Packiam
Expert Opinion on Pharmacotherapy|October 16, 2023
Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancerMohamad Abou Chakra, Vignesh T Packiam, Michael A O'Donnell
Annals of Surgical Oncology|February 10, 2026
ASO Practice Guidelines Series: Surgical Management of Bladder Cancer RelapseCan Aydogdu, Sean T McSweeney, Vignesh T Packiam, et al.
Pageof 14